Stay updated on Clinical Trial: Nivolumab in HCC with Electroporation
Sign up to get notified when there's something new on the Clinical Trial: Nivolumab in HCC with Electroporation page.

Latest updates to the Clinical Trial: Nivolumab in HCC with Electroporation page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded Hepatocellular Carcinoma as the study condition and a Resources link to Genetic and Rare Diseases Information Center. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check26 days agoChange DetectedRevision log updated to include v3.4.3 and remove v3.4.2.SummaryDifference0.1%

- Check55 days agoChange DetectedSite-wide revision updates were applied (Revision: v3.4.2) with removal of the prior funding/operating status notice (Revision: v3.4.1), which does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedAdded a government funding status notice. Updated the site to revision v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check69 days agoChange DetectedAdded Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0 to the page. Removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 from the page.SummaryDifference0.2%

- Check83 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous Revision: v3.3.3.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Nivolumab in HCC with Electroporation
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Nivolumab in HCC with Electroporation page.